National Institute of Mental Health; Notice of Closed Meetings, 66043 [2016-23042]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices
mstockstill on DSK3G9T082PROD with NOTICES
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Kidney, Urologic and
Hematologic Diseases D Subcommittee.
Date: October 19–20, 2016.
Open: October 19, 2016, 8:00 a.m. to 8:30
a.m.
Agenda: To review policy and procedures.
Place: Embassy Suites Hotel, 4300 Military
Road, Washington, DC 20015.
Closed: October 19, 2016, 8:30 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Hotel, 4300 Military
Road, Washington, DC 20015.
Closed: October 20, 2016, 8:00 a.m. to 2:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Hotel, 4300 Military
Road, Washington, DC 20015.
Contact Person: Barbara A. Woynarowska,
Ph.D., Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 7009, 6707
Democracy Boulevard Bethesda, MD 20892–
5452, (301) 402–7172, woynarowskab@
niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review; Group; Digestive Diseases and
Nutrition C Subcommittee.
Date: October 19–21, 2016.
Open: October 19, 2016, 6:00 p.m. to 6:30
p.m.
Agenda: To review policy and procedures.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Closed: October 19, 2016, 6:30 p.m. to 8:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Closed: October 20, 2016, 8:00 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Closed: October 21, 2016, 8:00 a.m. to
11:00 a.m.
VerDate Sep<11>2014
19:40 Sep 23, 2016
Jkt 238001
66043
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Robert Wellner, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, rw175w@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Diabetes,
Endocrinology and Metabolic Diseases B
Subcommittee.
Date: October 26–28, 2016.
Open: October 26, 2016, 5:00 p.m. to 5:30
p.m.
Agenda: To review policy and procedures.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA
22202.
Closed: October 26, 2016, 5:30 p.m. to 8:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA
22202.
Closed: October 27, 2016, 8:00 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA
22202.
Closed: October 28, 2016, 8:30 a.m. to 6:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA
22202.
Contact Person: John F. Connaughton,
Ph.D., Chief, Chartered Committees Section,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 7005, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7797, connaughtonj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
R61/R33 Early Phase Clinical Trials.
Date: November 1, 2016.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: David I. Sommers, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Blvd., Room 6154, MSC 9606,
Bethesda, MD 20892–9606, 301–443–7861,
dsommers@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
R01—Non-Pharmacological Confirmatory
Efficacy Clinical Trials.
Date: November 1, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: David I. Sommers, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Blvd., Room 6154, MSC 9606,
Bethesda, MD 20892–9606, 301–443–7861,
dsommers@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: September 20, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: September 20, 2016.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–23040 Filed 9–23–16; 8:45 am]
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2016–23042 Filed 9–23–16; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 81, Number 186 (Monday, September 26, 2016)]
[Notices]
[Page 66043]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23042]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; R61/R33 Early Phase Clinical Trials.
Date: November 1, 2016.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: David I. Sommers, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, National Institutes of Health, 6001 Executive Blvd.,
Room 6154, MSC 9606, Bethesda, MD 20892-9606, 301-443-7861,
dsommers@mail.nih.gov.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; R01--Non-Pharmacological Confirmatory Efficacy
Clinical Trials.
Date: November 1, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: David I. Sommers, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, National Institutes of Health, 6001 Executive Blvd.,
Room 6154, MSC 9606, Bethesda, MD 20892-9606, 301-443-7861,
dsommers@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants, National Institutes of Health, HHS)
Dated: September 20, 2016.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-23042 Filed 9-23-16; 8:45 am]
BILLING CODE 4140-01-P
